Latest Strategy News

Stakk Limited reveals a striking 566% year-to-date growth in annual recurring revenue, driven by its pivot to a B2B embedded finance platform and strategic US market expansion. The company also secured a $15 million institutional placement, underpinning its ambitious growth plans.

Bayan Mining has locked in an exclusive worldwide licence for advanced rare earth processing technologies developed at Colorado School of Mines, promising higher recovery rates and lower costs for its Desert Star Project near Mountain Pass.

Australian Oil Company Limited has signed binding agreements to acquire strategic oil and gas assets in Queensland's Surat Basin, positioning itself for production growth and exploration opportunities.

Solara Minerals has initiated a 2,800m drilling campaign at its Degrussa West Project, targeting promising gold-copper zones near the renowned Degrussa Mine, supported by recent government funding.

Pilot Energy has sold its option to lease a solar development site to Strike Energy, a move prompted by recent government policy changes excluding blue hydrogen from key tax incentives.

Almonty Industries has priced an upsized US$112.5 million share offering to accelerate development of key tungsten and molybdenum projects, reinforcing its position amid tightening global supply chains.

Medallion Metals and IGO Limited have agreed to extend the deadline for completing the Forrestania Nickel Operation acquisition, allowing more time to meet key conditions and secure environmental approvals.

Talga Group has successfully raised A$14.5 million through a placement to accelerate its anode production scale-up and explore expansion opportunities in the US, supported by a significant Swedish government grant.

Torque Metals has raised $15 million in a placement led by top-tier global investors, setting the stage for an aggressive drilling campaign at its Paris Gold Project in Western Australia.

High-Tech Metals Limited is advancing near-term gold production at its Mt Fisher and Mt Eureka projects, leveraging historical stockpiles and high-grade resources while pursuing aggressive exploration to expand its resource base.

Memphasys Limited has restructured its leadership by eliminating the CEO role to back a direct-selling global commercialisation strategy for its Felix™ System, anticipating imminent CE Mark approval to enter the European IVF market.

LTR Pharma has received regulatory clearance from the Therapeutic Goods Administration to commence its Phase II clinical trial of SPONTAN, focusing on men aged 65 and over. Patient recruitment is set to begin early next year, aiming to address a key gap in erectile dysfunction treatment.